TP53 and neuroendocrine carcinoma: CL4 showed an expression profile hierarchically linked to neuroendocrine carcinomas (LCNECs and SCLCs), with the greatest number of cases with simultaneous inactivation of TP53 and RB1, and a transcriptomic profile associated with hypomethylation-related signatures.